Our live Investing Matters Podcast Special which took place at the Master Investor Show discussing 'How undervalued is the UK stock market?', has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 62.00
Bid: 61.00
Ask: 63.00
Change: -1.50 (-2.36%)
Spread: 2.00 (3.279%)
Open: 63.50
High: 63.50
Low: 62.00
Prev. Close: 63.50
CLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of EGM-Replacement

2 Jul 2007 17:36

Calyx Group PLC02 July 2007 Correction - In the Result of EGM announcement released today (RNS 4875Z), thedate of the three meetings was incorrect. The date of the three meetings wasMonday 2 July 2007 and has been correctly disclosed in the announcement below.No other changes have been made to this announcement. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO ORFROM ANY RESTRICTED JURISDICTION Calyx Group plc ("Calyx" or the "Company") Result of Court Meetings and EGM The First Court Meeting was held on Monday, 2 July 2007 to enable CalyxShareholders (other than the Stornoway Class Shareholders) to consider and, ifthought fit, approve the Scheme. The resolution was decided on a poll and theresolution proposed was passed. The number of votes for and against theresolution were as follows: Shares Shareholders (either in person or by proxy) Number % Number %For 31,453,240 99.99% 48 98%Against 1,000 N/A 1 2% The Second Court Meeting was held on Monday, 2 July 2007 to enable StornowayClass Shareholders to consider and, if thought fit, approve the Scheme. Theresolution was decided on a poll and the resolution proposed was passed. Thenumber of votes for and against the resolution were as follows: Shares Shareholders (either in person or by proxy) Number % Number %For 21,419,738 100% 3 100%Against - - - - An Extraordinary General Meeting was held on Monday, 2 July 07 and allresolutions proposed to Calyx shareholders were duly passed. The number ofvotes for and against the resolutions were as follows: Shares Shareholders (either in person or by proxy) Number % Number %Resolution 1 - Ordinary ResolutionFor 50,471,661 99.99% 48 98%Against 1,000 N/A 1 2% Resolution 2 - Special ResolutionFor 50,471,661 99.99% 48 98%Against 1,000 N/A 1 2% Resolution 3 - Special ResolutionFor 50,471,661 99.99% 48 98%Against 1,000 N/A 1 2% Resolution 4 - Ordinary ResolutionFor 50,471,661 99.99% 48 98%Against 1,000 N/A 1 2% Resolution 5 - Simple Majority of votes cast by Independent Shareholders on a pollFor 30,333,923 99.9% 49 98%Against 1,000 N/A 1 2% The anticipated timeline of the remaining principal events required to implementthe Scheme is as follows: Intended Cancellation Record Time: 6.00 pm on 17 July 2007Intended date for Court Hearing (of the petition to sanction the 18 July 2007Scheme):Intended Transfer Record Time: 6.00 pm on 22 July 2007Last day of trading of Calyx Shares on AIM and IEX: 20 July 2007Intended Effective Date of the Scheme: 23 July 2007Dispatch of cheques/electronic settlements (as appropriate): No later than 6 August 2007 Capitalised terms in this announcement have the same meaning as in the SchemeDocument dated 8 June 2007. Enquiries: Calyx Group plc: +353 (0) 1 883 5555Gary Kennedy Davy Corporate Finance: +353 (0) 1 679 6363Financial Adviser to Calyx Group plcRonan GodfreyJohn Frain Murray Consultants: +353 (0) 1 498 0300Public Relations adviser to Calyx Group plcEd Micheau Deloitte Corporate Finance: +44 (0) 20 7936 3000Financial Adviser to Stornoway LimitedJonathan HintonDavid Smith Buchanan Communications: +44 (0) 20 7466 5000Public Relations adviser to Stornoway LimitedTim ThompsonJames Strong The Directors of Calyx accept responsibility for the information contained inthis announcement. To the best of their knowledge and belief (having taken allreasonable care to ensure that such is the case), the information contained inthis announcement for which they take responsibility is in accordance with thefacts and does not omit anything likely to affect the import of suchinformation. This announcement is not intended to and does not constitute an offer to sell orsubscribe for or an invitation to purchase or subscribe for any securities orthe solicitation of any vote or approval in any jurisdiction pursuant to theAcquisition or otherwise. Any response in relation to the Acquisition should bemade only on the basis of the information in the Scheme Document or any documentby which the Acquisition and Scheme are made. Davy Corporate Finance, which is authorised in Ireland by the FinancialRegulator under the Investment Intermediaries Act 1995, is acting exclusivelyfor Calyx and no-one else in connection with the Acquisition and will not beresponsible to anyone other than Calyx for providing the protections afforded toclients of Davy Corporate Finance or for providing advice in relation to theAcquisition. Deloitte Corporate Finance is acting exclusively for Stornoway and no-one elsein connection with the Acquisition and will not regard any other person as itsclient nor be responsible to anyone other than Stornoway for providing theprotections afforded to clients of Deloitte Corporate Finance nor for providingadvice in relation to the Acquisition, or any matter referred to in thisannouncement. Deloitte Corporate Finance is a division of Deloitte & Touche LLP,which is authorised and regulated by the Financial Services Authority in respectof regulated activities. The distribution of this announcement in or into certain jurisdictions may berestricted by the laws of those jurisdictions. Accordingly, copies of thisannouncement and all other documents relating to the Acquisition are not being,and must not be, mailed or otherwise forwarded, distributed or sent in, into orfrom any Restricted Jurisdiction. Persons receiving such documents (including,without limitation, nominees, trustees and custodians) should observe theserestrictions. Failure to do so may constitute a violation of the securities lawsof any such jurisdiction. Any person who is a holder of one per cent. or more of the Calyx Shares may havedisclosure obligations under Rule 8.3 of the Takeover Rules, effective from thedate of the commencement of the offer period in respect of the Acquisition. 2 July, 2007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Feb 20249:28 amRNSExercise of Options
14th Feb 20241:08 pmRNSExercise of Options
12th Dec 20233:47 pmRNSPDMR Dealings
21st Nov 20237:00 amRNSInterim Results
1st Nov 202312:24 pmRNSChange of Nominated Adviser
26th Oct 20237:00 amRNSNotice of Investor Presentation
10th Oct 20233:17 pmRNSTrading Update and Notice of Results
25th Aug 20234:36 pmRNSPDMR Dealings
16th Aug 20231:22 pmRNSResult of AGM
16th Aug 20237:00 amRNSAGM Statement
11th Aug 20232:00 pmRNSLong-Term Incentive Plan Awards
17th Jul 20237:00 amRNSNotice of AGM
12th Jul 202312:05 pmRNSDirector/PDMR Dealings
12th Jun 20234:34 pmRNSPDMR Dealings
23rd May 20237:00 amRNSFY23 Final Results
11th May 20239:00 amRNSPDMR Dealings
4th May 20237:00 amRNSNotice of Results and Investor Presentation
14th Apr 20236:03 pmRNSPDMR Dealings
14th Apr 20233:24 pmRNSDirector Dealing
15th Mar 20231:15 pmRNSDirector Dealings
14th Mar 20234:00 pmRNSPDMR Dealings
7th Mar 20239:05 amRNSSecond Price Monitoring Extn
7th Mar 20239:00 amRNSPrice Monitoring Extension
7th Mar 20237:00 amRNSTrading Update
15th Feb 202310:59 amRNSPDMR Dealings
19th Jan 20239:56 amRNSPDMR Dealings
17th Jan 20239:56 amRNSDirector / PDMR Dealings
17th Jan 20239:52 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSBoard Changes
13th Jan 20234:00 pmRNSDirector/PDMR Dealing
13th Dec 20222:15 pmRNSDirector / PDMR Dealings
22nd Nov 20227:00 amRNSInterim Results
21st Nov 20225:43 pmRNSDirector / PDMR Dealings
27th Oct 20227:00 amRNSNotice of Results and Investor Presentation
14th Oct 20223:53 pmRNSDirector/PDMR Shareholding
12th Oct 20221:29 pmRNSDirector / PDMR Dealings
15th Sep 20227:30 amRNSDirector/PDMR Dealing
17th Aug 20225:26 pmRNSResult of AGM
17th Aug 20227:00 amRNSAGM Statement
15th Aug 202210:26 amRNSDirector / PDMR Dealings
26th Jul 20223:33 pmRNSDirector / PDMR Shareholding
18th Jul 20227:00 amRNSNotice of AGM
14th Jul 20225:49 pmRNSDirector/PDMR Dealings
8th Jul 20226:01 pmRNSDirector / PDMR dealings
15th Jun 20227:00 amRNSExercise of Options
14th Jun 20227:00 amRNSBoard Update
6th Jun 20221:30 pmRNSDirector Dealing
24th May 20227:00 amRNSFY22 Final Results
6th May 20227:00 amRNSNotice of Investor Presentation
26th Apr 20229:13 amRNSAward of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.